$23.54+0.34 (+1.49%)
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. in the Healthcare sector is trading at $23.54 with a market capitalization of $2.9B. Wall Street consensus targets $24.92 (13 analysts), implying a +5.9% move over the next 12 months. The stock is currently near its 52-week high of $23.87, remaining 24.6% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.24B↑ | $1.01B↑ | $993.70M↓ | $1.02B↑ | $926.93M |
| Gross Profit | $144.48M↑ | $123.31M↓ | $125.67M↓ | $133.55M↑ | $106.03M |
| Operating Income | $15.50M↑ | -$10.28M↓ | $7.68M↓ | $22.75M↑ | -$5.39M |
| Net Income | $11.42M↑ | -$11.01M↓ | $3.73M↓ | $15.67M↑ | -$9.11M |
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. wa...
Alignment Healthcare, a tech-driven Medicare Advantage provider, reported a notable insider sale amid a year of strong share price gains.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
ALHC, AGX, AGYS and CIEN make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
Alignment Healthcare currently trades at $19.95 per share and has shown little upside over the past six months, posting a small loss of 2.9%. The stock also fell short of the S&P 500’s 12.4% gain during that period.
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.